|
Volumn 10, Issue 6, 2013, Pages
|
Rising Health Care Costs and Life-Cycle Management in the Pharmaceutical Market
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
CETIRIZINE;
ESOMEPRAZOLE;
EZETIMIBE PLUS SIMVASTATIN;
LEVOCETIRIZINE;
METFORMIN;
OMEPRAZOLE;
SIMVASTATIN;
ARTICLE;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
DRUG MANUFACTURE;
HEALTH CARE COST;
HEALTH INSURANCE;
HUMAN;
PUBLIC HEALTH;
UNIVERSITY HOSPITAL;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
MALE;
NONPRESCRIPTION DRUGS;
PATENTS AS TOPIC;
|
EID: 84879399217
PISSN: 15491277
EISSN: 15491676
Source Type: Journal
DOI: 10.1371/journal.pmed.1001461 Document Type: Article |
Times cited : (12)
|
References (8)
|